The Enterprise Value as of December 2025 (TTM) for AmCad BioMed Corporation (4188.TWO) is 963.15M

According to AmCad BioMed Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 963.15M. This represents a change of -22.51% compared to the average of 1.24B of the last 4 quarters.

AmCad BioMed Corporation (4188.TWO) Historical Enterprise Value (quarterly & annually)

How has 4188.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of AmCad BioMed Corporation over the last ten years is 1.13B. The current 963.15M Enterprise Value has changed 8.44% with respect to the historical average. Over the past ten years (40 quarters), 4188.TWO's Enterprise Value was at its highest in in the March 2024 quarter at 1.58B. The Enterprise Value was at its lowest in in the December 2022 quarter at 805.89M.

AmCad BioMed Corporation (4188.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AmCad BioMed Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AmCad BioMed Corporation (4188.TWO) Average Enterprise Value

How has 4188.TWO Enterprise Value performed in the past?

The current Enterprise Value of AmCad BioMed Corporation (4188.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

AmCad BioMed Corporation (4188.TWO) Enterprise Value vs. Peers

How is 4188.TWO’s Enterprise Value compared to its peers?

AmCad BioMed Corporation’s Enterprise Value is greater than PlexBio Co., Ltd. (711.81M), greater than TFBS Bioscience Inc. (559.94M), greater than Puriblood Medical Co., Ltd. (953.06M), greater than SynCore Biotechnology Co.,Ltd (734.47M), greater than NatureWise Biotech & Medicals Corporation (897.80M), greater than Radiant Innovation Inc. (764.45M), greater than Eusol Biotech Co.,Ltd. (663.47M), less than Andros Pharmaceuticals Co.,Ltd (1.26B), less than LAUNXP Biomedical Co., Ltd (1.02B), less than General Biologicals Corporation (3.06B),

Build a custom stock screener for AmCad BioMed Corporation (4188.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AmCad BioMed Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AmCad BioMed Corporation (4188.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AmCad BioMed Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.